- Benchmark ASINB0FDR7TNN7
- MarketplaceUS
- Category ID8627079011
- Analyzed Products
- Keywordhome health
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-25
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
这个市场不值得进入，而且已经是同质化严重、利润被压薄的低回报市场。现有数据里没有看到新的健康机会：新品牌数量为0，新品牌新上架成功率为0.00%，所有可见新上架样本都没跑通；这不是“挑对产品就能赢”的市场，而是“进去后大概率被价格和投放拖死”的市场。
RLEXIO 是当前最能代表这个类目的品牌样本，但它也没给出可复制的好结果：2个可识别产品里，盈利产品0个、亏损产品2个，品牌盈利率0%；旧款 B0FDR7TNN7 售价 9.22 美元，月销50件，月营收 461 美元，利润率只有 11.9%，已经贴近价格战边缘；新款 B0GSQTYSV7 直接失败，说明新品更难跑通。产品形态也几乎没差异，都是标准电极贴+导线组合，成功和失败都显示出“缺少独特性、市场小、竞争极强”。从趋势看，最近几个月没有出现可验证的新增盈利样本，2026年新增样本仅1个且为失败，市场是停滞偏弱，不是成长型。
对大品牌来说，确实有预算上的进入能力：你的 500000 CNY 足够覆盖单个ASIN前期投放和铺货，但这不能改变类目本身利润太薄的事实；如果没有明显的功能升级、设计差异或渠道优势，强行进场也很难赚钱。对小商家来说，更没有可参考的健康成功案例，尤其没有<300评论的真实胜出样本，意味着小品牌即使能进，也大概率要靠激进投放和低价去硬拼，这种打法风险很高。结论很直接：不要进入。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
Old Brands
#Budget Requirement
Listing结论很明确：这个市场不适合进入。 用户预算500000 CNY看起来足够覆盖单个ASIN前期投入，但市场本身已经进入高风险、低回报状态：整体可识别盈利率只有0.00%，新发布产品盈利率也是0.00%，而且唯一可见的老品牌RLEXIO新款B0GSQTYSV7直接失败，说明不是“钱不够”，而是“进场后也很难赚到钱”。
从证据看，RLEXIO作为老品牌在这个类目里有2个可识别产品，1个旧款B0FDR7TNN7卖到241条评论、月销50件、月收入46100 USD，但利润率只有11.9%，已经接近价格战边缘；它的新款B0GSQTYSV7则没有销量、没有利润，属于典型的新品失利。产品形态也几乎没有差异化：B0GSQTYSV7和B0FDR7TNN7都只是标准电极贴+导线组合包，和市面通用替换件高度重叠，说明这个类目没有足够创新空间，靠常规上新很难做出15%以上的健康利润。再加上市场样本里目前只有1个可识别收入产品、总样本收入仅461 USD，结合0.00%的盈利率，这不是成长型机会，而是被低价和同质化挤压的市场。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?100.00%New listing success rate (old brands):0.00%Alternatives- 购买通用TENS电极垫替换装，但不绑定同品牌套装：优先选更低价的兼容款单独补货，适合只想继续使用现有理疗仪的用户，通常比整套更便宜也更容易买到。
- 改买标准2mm/2.35mm接头的通用导线+少量电极垫组合，放弃“20片大包装”，用更小规格先解决断线或接触不良问题，采购门槛更低。
- 直接购买“自粘电极片”第三方通用耗材，不追求原厂品牌，适合对疗效要求一致但更在意低单价和快速替换的用户。
- 改用一次性理疗贴/热敷贴这类非电子耗材，虽然效果机制不同，但在很多轻度疼痛场景下更省事、无需配线、也不依赖设备。
- 如果主要问题是局部疼痛与肌肉僵硬，转向更低成本的手持按摩球、筋膜球或泡沫轴，作为无电源替代方案，使用更简单、维护成本更低。
- 对已有TENS设备的用户，可选择只买“导线备用件”而不是整盒彩贴，先修复最容易坏的部件，降低一次性支出并延长现有设备寿命。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，已经明显偏向价格战，而且没有看到新品牌的有效盈利样本。已披露数据里，整体可判断盈利的产品里盈利率是0.00%，新上架产品盈利率也是0.00%；同时老品牌 RLEXIO 的新上架产品 B0GSQTYSV7 直接亏损，说明现在的竞争不是“能不能做”，而是“谁愿意烧得更多”。
证据很直接：RLEXIO 作为老品牌，在这个类目里有 2 个可识别产品，盈利产品 0 个、亏损产品 2 个，品牌盈利率 0%；它的新款 B0GSQTYSV7 也是亏损，上市于 2026-03，属于新上架却没跑通的典型。唯一能看的旧款是 B0FDR7TNN7，售价 $9.22，月销量 50，月营收 $461，但利润率只有 11.9%，仍被判为非盈利；更关键的是，做出这点销量的早期投入就达到 $1,314.96，其中广告约 $295.60。这说明在低客单价下，利润空间已经被物流、平台费和获客成本吃得很薄。市场节奏上，2026 年只看到 1 个新上架且为亏损产品，近几个月没有新的成功样本，趋势不是上升，而是停滞偏弱。
对大品牌来说，可参考的只有 RLEXIO / B0FDR7TNN7 这种老牌低价走量款，但它也只是勉强跑量、没跑出利润；对小商家来说，没有真正的成功案例，更没有 <300 reviews 的健康样本，当前更像是“靠价格和投放硬顶”的竞争环境。若硬要做，必须准备至少覆盖首批补货、广告和隐藏成本的资金，按这个样本看，单个 ASIN 仅前期就要千美元级投入，而你的预算 500,000 CNY 虽然够启动，但不代表足够安全；在没有差异化和更高利润率前，进入只会被拖进低毛利甚至亏损。
Old brand with the most profitable new productsRLEXIO
Recent Monthly Revenue (USD):-(-)B0GSQTYSV7Brand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (USD):$461.00(50pcs/month)B0FDR7TNN7 (4.5/5 (241 Reviews))Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0GSQTYSV7Brand is an old entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQSales & BSR
Differentiation:- Product features and designs are too common without differentiation
B0FDR7TNN7 (4.5/5 (241 Reviews))Brand is an old entry in this marketOld ReleaseInsufficient Sales to Meet MOQOld ReleaseNot enough sales volume to meet 100 MOQSales & BSR
#Net Profit Margins: All vs New
Listing这个市场不值得进入：已经进入低利润、弱增长的高风险区，而且当前可见的新进入样本几乎没有真正成功案例。 现有数据里，已确认的产品只有 2 个，利润率分别是 11.9% 和未披露；新产品只有 1 个可见样本，且是非盈利，说明新进场不是机会型市场，而是被老品牌和低利润挤压的市场。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Non-Profitable Products
Products with negative profitability ranked by lowest profit value. Only includes products classified as non-profitable regardless of release date.
B0FDR7TNN7RLEXIO2025-07-01No$9.2250pcs$461.011.9%$54.86B0GSQTYSV7RLEXIO2026-03-16No$--pcs$--%$-Top 20 Non-Profitable New Products
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
B0GSQTYSV7RLEXIO2026-03-16No$--pcs$--%$-#New Product Success Rates
Listing这个市场不值得进入，已经接近价格战/高度内卷区，且现有证据显示新产品几乎没有成功空间。 目前新上架产品成功率为0%，市场盈利产品比例也是0%；更关键的是，已出现的唯一新产品 B0GSQTYSV7 直接失败，而同类样本 B0FDR7TNN7 也同样不盈利，说明这里不是“少数选手赢”，而是“几乎都难赚”。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableNo data availableNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
RLEXIO#Success Rate by Entry Time
Listing这个市场不适合现在进入，结论很直接：新品几乎没有真实成功样本，且最近释放的产品只有 1 个可追踪案例，结果还是失败。 现有数据看不到健康的新增机会，反而更像是被老品牌和强营销挤压的市场；对大品牌和小商家都不成立为“高成功率”市场。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 0 0 1 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 0 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 1 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 0 0 0 2026/6 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success Cases